Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00215254
Status:
COMPLETED
Last Update Posted:
2006-12-19
First Post:
2005-09-20
Brief Title:
Quetiapine in Social Anxiety Disorder
Sponsor:
Duke University
Organization:
Duke University
Study Overview
Official Title:
A Randomized Double-Blind Placebo-Controlled Pilot Study of Quetiapine in Social Anxiety Disorder
Status:
COMPLETED
Status Verified Date:
2006-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to examine the effectiveness and tolerability of quetiapine for the treatment of social anxiety disorder SAD The hypothesis is that quetiapine will be effective and well-tolerated for patients with social anxiety disorder
Detailed Description:
This is an eight week randomized double-blind placebo-controlled trial of quetiapine 100-400 mgdayin social anxiety disorder
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None